International Stem Cell Corporation Announces Second Patient with Parkinson’s Disease Treated in Phase I Clinical Trial – Yahoo Sports
|
International Stem Cell Corporation Announces Second Patient with Parkinson's Disease Treated in Phase I Clinical Trial
Yahoo Sports 07, 2016 (GLOBE NEWSWIRE) — International Stem Cell Corporation (ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced the treatment of the second patient in … |
